October 7th, 2013
A Novel Risk Score for Predicting MACE in Patients with Vasospastic Angina
Hiroaki Shimokawa, MD, PhD
Hiroaki Shimokawa discusses his research group’s JACC study, in which they developed a comprehensive clinical risk score for VSA patients.
November 5th, 2012
Reclassifying AHA on the West Coast
Amit Shah, MD, MSCR
An evening epidemiology session highlights the value of AHA.12, as a fellow garners multiple insights from a series of speakers.
March 12th, 2012
Selections from Richard Lehman’s Weekly Review: Week of March 12th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include stem cells for the heart, BP in both arms and vascular disease, and how patients and caregivers interpret prognostic information.
April 12th, 2011
Two Studies Try to Improve Risk Prediction for Kidney Disease Progression
Larry Husten, PHD
Two papers presented at the World Congress of Nephrology and simultaneously published online in JAMA raise hope for better tools to calculate the risk for developing kidney failure, but the techniques are not yet ready for clinical use, according to an accompanying editorial. In the first study, Carmen Peralta and colleagues evaluated a triple-marker strategy combining […]
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?